C0007806||cerebrospinal fluid
C0002395||Alzheimer's disease
C0005516||biomarkers
C0430022||diagnostic
C0220825||evaluation
C0497327||dementia
C1706852||article
C0441800||Grading
C0220825||Assessment
C2911685||Evaluation method
C4084924||clinical application
C0007806||cerebrospinal fluid
C0007806||cerebrospinal fluid
C0169424||amyloid-Î²1-42
C0085401||tau
C1519061||phosphorylated
C0085401||tau
C0430022||diagnostic
C0220825||evaluation
C0497327||dementia
C1883562||working group
C0002395||Alzheimer's disease
C0002395||Alzheimer's disease
C0497327||dementia
C0234985||decline
C3526596||interpretation of results
C1883562||working group
C0007806||cerebrospinal fluid
C0002395||Alzheimer's disease
C0005516||biomarkers
C0008972||clinical
C0220825||evaluation
C0087130||uncertain
C0002395||Alzheimer's disease
C0497327||dementia
C0087130||uncertain
C0007806||cerebrospinal fluid
C0002395||Alzheimer's disease
C0005516||biomarkers
C0005516||imaging biomarkers
C0007806||cerebrospinal fluid
C0005516||biomarker